FSH (Serono/Alkermes)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameFSH (Serono/Alkermes)
Drug Alias NameProLease FSH (Serono/Alkermes)r-FSH (Serono/Alkermes)r-hFSH (Serono/Alkermes)FSH (Serono/Alkermes)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionFollicle-stimulating hormone receptor agonists
TargetsFollicle-stimulating hormone receptor
Therapy Area/IndicationsInfertility
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwitzerland
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Serono Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Serono SaAlkermes Plc
Active IndicationsN/A
Inactive IndicationsInfertility

Other Information

ATC CodeN/A
Related LinksN/A